Germany – Pharmaceutical products – Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren
Description
The IKK classic hereby announces that it will enter into non-exclusive discount agreements in accordance with Section 130a(8) SGB V, on equal, non-negotiable terms, with all interested and suitable pharmaceutical companies for various active substances and combinations of active substances, from 01.03.2026 to 29.02.2028. The earliest contract start date is 01.03.2026, provided that the signed contract and all necessary evidence, declarations, and documents are received by IKK classic by 05.02.2026. Thereafter, the following applies: if the documents are received by the 05th of any month within the possible entry period, the contract will commence on the 1st of the following month. If the documents are received after the 05th of any month within the possible entry period, the contract will commence on the 1st of the second following month. Entry into the agreement is possible at any time within the specified period, but at the latest by 05.01.2028. Further details see section VI.3.
CPV codes
Documents & submission
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Related tenders
Germany – Medical equipments, pharmaceuticals and personal care products – 1/DLII6/VM137 - RV Medizinprodukte, divers
Bundesamt für Infrastruktur, Umweltschutz und Dienstleistungen der BundeswehrGermanyMedical equipments, pharmaceuticals and personal care productsDeadline in 6 daysPublished on Oct 19, 2026
Germany – Medical breathing devices – Beschaffung von 17 Intensivbeatmungsgeräten
Hochtaunus Kliniken gGmbHGermanyMedical breathing devicesDeadline in 34 daysPublished on Oct 19, 2026
Germany – Pharmaceutical products – Open-House-Rabattverträge 2026-18
Techniker KrankenkasseGermanyPharmaceutical productsDeadline in 772 daysPublished on Oct 19, 2026
Germany – Pharmaceutical products – Open-House-Rabattverträge 2026-17 Tafamidis
Techniker KrankenkasseGermanyPharmaceutical productsDeadline in 772 daysPublished on Oct 19, 2026